MethOxyfluraNe in InTerventiOnal Radiology (MONITOR): A randomised controlled trial

Ross Copping1,2, Paul Balamon1, Marcus Lau1

  • 1Interventional Radiology Department, Liverpool Hospital, Sydney, New South Wales, Australia.

Abstract

Insights

Methoxyflurane effectively reduced pain and anxiety during interventional radiology (IR) procedures. This study found methoxyflurane to be a safe and beneficial option for analgesia and anxiolysis in IR.

Area of Science:

  • Medical research
  • Anesthesiology
  • Interventional Radiology

Background:

  • Procedural sedation and pain management are crucial in interventional radiology (IR) but are under-researched.
  • Methoxyflurane, known for rapid onset/offset and a good safety profile, has been used in minor procedures.

Purpose of the Study:

  • To evaluate the efficacy and safety of methoxyflurane for sedation and pain management in interventional radiology (IR) procedures.

Main Methods:

  • A randomized, double-blind, placebo-controlled trial involving 314 patients undergoing portacath insertion/removal or solid organ biopsy.
  • Patients received either methoxyflurane or placebo via a Penthrox inhaler.
  • Pain and anxiety scores (Visual Analogue Scale) were measured pre-procedure, during, and post-procedure.

Main Results:

  • The methoxyflurane group experienced significantly lower pain and anxiety scores throughout the procedure compared to placebo (P < 0.001).
  • Methoxyflurane resulted in 2.5 times less pain and 1.6 times less anxiety on average during procedures.
  • No major drug or procedure-related adverse events were reported in the methoxyflurane group.

Conclusions:

  • Methoxyflurane demonstrates safety and effectiveness in providing analgesia and anxiolysis for select interventional radiology procedures.
  • The findings support methoxyflurane as a valuable option for pain and anxiety management in IR.